Administration of Subcutaneous IL-2 is Associated with Strong Induction of Regulatory T Cells in High-Risk Neuroblastoma Patients Treated with Dinutuximab Beta, A SIOPEN Study
PEDIATRIC BLOOD & CANCER(2019)
AI Read Science
Must-Reading Tree
Example
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined